GLP 1
Exenatide How It Works: Mechanism of Action Explained
Exenatide was the first GLP-1 receptor agonist approved by the FDA, back in April 2005, under the brand name Byetta.
Exenatide Latest Research: New Indications, Trials and Whats Coming
Exenatide is the oldest GLP-1 receptor agonist on the market, approved in 2005.
Exenatide Who Should (and Shouldnt) Take It: Eligibility and Contraindications
Introduction Exenatide is FDA-approved for type 2 diabetes in adults as an add-on to diet and exercise, either as monotherapy or in combination with…
Exenatide Drug Interactions: What You Can and Cant Take with It
Introduction Exenatide has fewer pharmacokinetic interactions than most diabetes drugs because it is a peptide, not metabolized by cytochrome P450 enzymes, and not significantly…
Exenatide Dosing Guide: Schedule, Titration & What to Expect Each Week
Exenatide comes in two very different formulations with very different dosing schedules.
Exenatide Cost Breakdown: Brand, Compounded, Insurance and Savings Options
Exenatide is one of the cheaper branded GLP-1 drugs in 2026, partly because it is no longer top-of-class for either diabetes or weight loss.
The Ethics of GLP-1 Marketing: DTC Advertising & Patient Autonomy
Direct-to-consumer pharmaceutical advertising is legal in only two countries, the United States and New Zealand. Everywhere else it’s banned.
Marathon/Endurance Training on GLP-1: Can You Do It Safely?
Endurance training and GLP-1 medications pull in opposite directions.
Emotional Eating After Starting GLP-1: How Habits Change
Most people who start semaglutide or tirzepatide come in thinking the drug will make them less hungry.
